ExodusPoint Capital Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-13,817
| Closed | -$46K | – | 1372 |
|
2024
Q4 | $46K | Sell |
13,817
-1,926
| -12% | -$6.41K | ﹤0.01% | 1304 |
|
2024
Q3 | $53K | Sell |
15,743
-1,817
| -10% | -$6.12K | ﹤0.01% | 1419 |
|
2024
Q2 | $58K | Hold |
17,560
| – | – | ﹤0.01% | 1309 |
|
2024
Q1 | $71K | Buy |
17,560
+798
| +5% | +$3.23K | ﹤0.01% | 1304 |
|
2023
Q4 | $51K | Sell |
16,762
-12,092
| -42% | -$36.8K | ﹤0.01% | 1309 |
|
2023
Q3 | $87K | Sell |
28,854
-13,381
| -32% | -$40.3K | ﹤0.01% | 1546 |
|
2023
Q2 | $158K | Buy |
+42,235
| New | +$158K | ﹤0.01% | 1621 |
|
2022
Q4 | – | Sell |
-11,293
| Closed | -$64K | – | 1573 |
|
2022
Q3 | $64K | Sell |
11,293
-434
| -4% | -$2.46K | ﹤0.01% | 1750 |
|
2022
Q2 | $83K | Buy |
+11,727
| New | +$83K | ﹤0.01% | 1709 |
|
2022
Q1 | – | Sell |
-23,959
| Closed | -$214K | – | 2120 |
|
2021
Q4 | $214K | Buy |
+23,959
| New | +$214K | ﹤0.01% | 1759 |
|